BACKGROUND: Comparison of two kinds of cannulation (double-lumen cannula [DLC, Avalon Elite Bicaval Dual Lumen Catheter] and conventional cannulation with two cannulas) for venovenous extracorporeal membrane oxygenation (ECMO) therapy in terms of effectiveness, usage complexity, and costs. METHODS: Retrospective case series of 17 patients who received venovenous ECMO therapy due to acute respiratory distress syndrome (ARDS) between January 2010 and March 2012. Nine patients were treated with the DLC and eight patients with conventional cannulation. We analyzed the outcome data, ECMO values, respirator settings, blood gas values, realized prone positioning, and costs, and compared both methods. RESULTS: Both kinds of cannulation are efficient regarding oxygenation and decarboxylation. There is no significant difference in mortality, hospitalization time (intensive care unit [ICU] and hospital) and complications during ECMO therapy between both groups. Cannula implantation is much more complex in the DLC group and requires more experience in TEE (transesophageal echocardiography) diagnostics and cannulation technique. In addition, the costs for the Avalon (MAQUET Cardiopulmonary AG, Germany) cannula are significantly higher than for conventional cannulation. Furthermore, prone positioning could be easier achieved in the DLC group. CONCLUSION: In summary, double-lumen cannulation allows sufficient gas exchange with more effort (material, technical, and physicians' experience) and higher costs but better mobilization possibilities (particularly prone position) and potential avoidance of deep sedation and mechanical ventilation. From the current point of view, the DLC should be reserved for special cases. Georg Thieme Verlag KG Stuttgart · New York.
BACKGROUND: Comparison of two kinds of cannulation (double-lumen cannula [DLC, Avalon Elite Bicaval Dual Lumen Catheter] and conventional cannulation with two cannulas) for venovenous extracorporeal membrane oxygenation (ECMO) therapy in terms of effectiveness, usage complexity, and costs. METHODS: Retrospective case series of 17 patients who received venovenous ECMO therapy due to acute respiratory distress syndrome (ARDS) between January 2010 and March 2012. Nine patients were treated with the DLC and eight patients with conventional cannulation. We analyzed the outcome data, ECMO values, respirator settings, blood gas values, realized prone positioning, and costs, and compared both methods. RESULTS: Both kinds of cannulation are efficient regarding oxygenation and decarboxylation. There is no significant difference in mortality, hospitalization time (intensive care unit [ICU] and hospital) and complications during ECMO therapy between both groups. Cannula implantation is much more complex in the DLC group and requires more experience in TEE (transesophageal echocardiography) diagnostics and cannulation technique. In addition, the costs for the Avalon (MAQUET Cardiopulmonary AG, Germany) cannula are significantly higher than for conventional cannulation. Furthermore, prone positioning could be easier achieved in the DLC group. CONCLUSION: In summary, double-lumen cannulation allows sufficient gas exchange with more effort (material, technical, and physicians' experience) and higher costs but better mobilization possibilities (particularly prone position) and potential avoidance of deep sedation and mechanical ventilation. From the current point of view, the DLC should be reserved for special cases. Georg Thieme Verlag KG Stuttgart · New York.
Authors: Martin Geyer; Bernhard Gohrbandt; Ingo Sagoschen; Thomas Hartmann; Felix Post; Christian-Friedrich Vahl; Thomas Münzel Journal: J Artif Organs Date: 2017-11-09 Impact factor: 1.731
Authors: Matthew J Griffee; Joshua M Zimmerman; Stephen H McKellar; Joseph E Tonna Journal: J Cardiothorac Vasc Anesth Date: 2019-10-18 Impact factor: 2.628
Authors: Ruslan Natanov; Abdurasul Khalikov; Faikah Gueler; Ulrich Maus; Erin C Boyle; Axel Haverich; Christian Kühn; Nodir Madrahimov Journal: Intensive Care Med Exp Date: 2019-12-16
Authors: Tobias Wengenmayer; Ralf M Muellenbach; Fabio Silvio Taccone; Markus Kredel; Armin Kalenka; Jan Bělohlávek; Tobias Spangenberg; Hendrik Haake; Hendrik Bracht; Onnen Moerer; Roberto Lorusso; Philipp M Lepper Journal: Am J Respir Crit Care Med Date: 2020-11-15 Impact factor: 21.405